Quarterly report pursuant to Section 13 or 15(d)

RESTATEMENT (Tables)

v3.19.2
RESTATEMENT (Tables)
6 Months Ended
Sep. 30, 2018
Consolidated balance sheets
 
 
QUANTUM CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands)
 
   
September 30, 2017
 
   
As Reported
   
Restatement
Adjustments
   
Restatement
Reference
   
As Restated
 
ASSETS
                               
Current Assets
                               
Cash and cash equivalents
  $ 9,504     $ 4,479       k     $ 13,983  
Accounts receivable,
    105,771       (6,545     a       99,226  
Manufacturing inventories
    29,119       5,593       a       34,712  
Service part inventories
    19,915       —                 19,915  
Other current assets
    8,795       786       g, q       9,581  
Restricted cash
    1,969       1,094       f       3,063  
   
 
 
   
 
 
           
 
 
 
Total current assets
    175,073       5,407               180,480  
Property and equipment, less accumulated depreciation
    10,745       (325     r       10,420  
Restricted cash, long-term
    20,000       —                 20,000  
Other long-term assets
    5,332       1,418       h, m, p, r       6,750  
   
 
 
   
 
 
           
 
 
 
Total assets
  $ 211,150     $ 6,500             $ 217,650  
   
 
 
   
 
 
           
 
 
 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
                               
Liabilities
                               
Current liabilities:
                               
Accounts payable
  $ 48,488       —               $ 48,488  
Accrued warranty
    2,950       (2,950     l       —    
Deferred revenue, current
    77,090       11,415       a, b       88,505  
Accrued restructuring charges, current
    1,743       627       i       2,370  
Convertible subordinated debt, current
    57,034       —                 57,034  
Accrued compensation
    23,180       (925     e, f       22,255  
Other accrued liabilities
    12,927       3,634       a, d, l, n, q, r       16,561  
   
 
 
   
 
 
           
 
 
 
Total current liabilities
    223,412       11,801               235,213  
Deferred revenue, long-term
    35,906       868       b       36,774  
Accrued restructuring charges, long-term
    423       3,192       i       3,615  
Long-term debt, net of current portion
    70,631       5,860       h, m       76,491  
Other long-term liabilities
    5,112       5,924       n, p, q       11,036  
   
 
 
   
 
 
           
 
 
 
Total liabilities
    335,484       27,645               363,129  
Commitment and contingencies (Note 12)
                               
Stockholders’ deficit
                               
Preferred stock
     —                      —  
Common stock
    347       —                 347  
Additional
paid-in
capital
    476,409       (316     j       476,093  
Accumulated deficit
    (604,832     (16,197     a, b, d, e, m, o,
p, q, r
      (621,029
Accumulated other comprehensive income (loss)
    3,742       (4,632     n, r       (890
   
 
 
   
 
 
           
 
 
 
Total stockholders’ deficit
    (124,334     (21,145             (145,479
   
 
 
   
 
 
           
 
 
 
Total liabilities and stockholders’ deficit
  $ 211,150     $ 6,500             $ 217,650  
   
 
 
   
 
 
           
 
 
 
Consolidated statements of operations
 
   
Six Months Ended September 30, 2017
 
   
As Reported
   
Restatement
Adjustments
   
Restatement
References
   
As Restated
 
Revenue:
                               
Product revenue
  $ 135,224     $ 1,855       a, c     $ 137,079  
Service revenue
    69,410       617       b       70,027  
Royalty revenue
    19,275       —                 19,275  
   
 
 
   
 
 
           
 
 
 
Total revenue
    223,909       2,472               226,381  
   
 
 
   
 
 
           
 
 
 
Costs and expenses:
                               
Product cost of revenue
    99,510       2,772       a       102,282  
Service cost of revenue
    29,807       135       d       29,942  
Total cost of revenue
    129,317       2,907               132,224  
   
 
 
   
 
 
           
 
 
 
Gross profit
    94,592       (435             94,157  
   
 
 
   
 
 
           
 
 
 
Operating expenses:
                               
Research and development
    20,795       —                 20,795  
Sales and marketing
    54,003       (1,101     c, e       52,902  
General and administrative
    24,667       (737     j, r       23,930  
Restructuring charges
    2,366       (665     i       1,701  
   
 
 
   
 
 
           
 
 
 
Total operating expenses
    101,831       (2,503             99,328  
   
 
 
   
 
 
           
 
 
 
Loss from operations
    (7,239     2,068               (5,171
Other expenses and losses, net:
                               
Interest expense, net
    5,175       42       r       5,217  
Loss on debt extinguishment
    39       —                 39  
Other income, net
    (175     —                 (175
   
 
 
   
 
 
           
 
 
 
Loss before income taxes
    (12,278     2,026               (10,252
Income tax benefit
    (741     (293     m, o, p, q       (1,034
   
 
 
   
 
 
           
 
 
 
Net loss
  $ (11,537   $ 2,319             $ (9,218
   
 
 
   
 
 
           
 
 
 
Net loss per share:
                               
Basic
  $ (0.34                   $ (0.27
Diluted
  $ (0.34                   $ (0.27
         
Weighted average common shares outstanding - basic
    34,337                       34,338  
Weighted average common shares outstanding - diluted
    34,337                       34,338  
 
 
   
Three Months Ended September 30, 2017
 
   
As Reported
   
Restatement
Adjustments
   
Restatement
References
   
As Restated
 
Revenue:
                               
Product revenue
  $ 63,606     $ 3,990       a, c     $ 67,596  
Service revenue
    34,165       745       b       34,910  
Royalty revenue
    9,280       —                 9,280  
   
 
 
   
 
 
           
 
 
 
Total revenue
    107,051       4,735               111,786  
   
 
 
   
 
 
           
 
 
 
Costs and expenses:
                               
Product cost of revenue
    48,561       3,041       a       51,602  
Service cost of revenue
    14,717       148       d       14,865  
Total cost of revenue
    63,278       3,189               66,467  
   
 
 
   
 
 
           
 
 
 
Gross profit
    43,773       1,546               45,319  
   
 
 
   
 
 
           
 
 
 
Operating expenses:
                               
Research and development
    10,190       —                 10,190  
Sales and marketing
    26,179       (355     c, e       25,824  
General and administrative
    12,158       (652     j, r       11,506  
Restructuring charges
    31       39       i       70  
   
 
 
   
 
 
           
 
 
 
Total operating expenses
    48,558       (968             47,590  
   
 
 
   
 
 
           
 
 
 
Loss from operations
    (4,785     2,514               (2,271
Other expenses and losses, net:
                               
Interest expense, net
    2,617       21       r       2,638  
Loss on debt extinguishment
    39       —                 39  
Other income, net
    (77     —                 (77
   
 
 
   
 
 
           
 
 
 
Loss before income taxes
    (7,364     2,493               (4,871
Income tax expense
    499       (271     m, o, p, q       228  
   
 
 
   
 
 
           
 
 
 
Net loss
  $ (7,863   $ 2,764             $ (5,099
   
 
 
   
 
 
           
 
 
 
Net loss per share:
                               
Basic
  $ (0.23                   $ (0.15
Diluted
  $ (0.23                   $ (0.15
         
Weighted average common shares outstanding - basic
    34,561                       34,580  
Weighted average common shares outstanding - diluted
    34,561                       34,580  
Consolidated statements of cash flows
   
For the Six Months Ended September 30, 2017
 
   
As Reported
   
Restatement
Adjustments
   
Restatement
Reference
   
As Restated
 
Cash flows from operating activities:
                               
Net loss
  $ (11,537   $ 2,319       a, b, e, f, g,
h, i, l, n, p, q
    $ (9,218
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
                               
Depreciation and amortization
    2,525       85       l, r       2,610  
Amortization of debt issuance costs
    855       —                 855  
Product and service parts lower of cost or market adjustment
    2,319       1,844       l       4,163  
Tax benefit from settlement
    (1,656     1,656       l       —    
Share-based compensation expense
    3,330       (317     l       3,013  
Non-cash
interest expense
    621       (621     l       —    
Non-cash
loss on debt extinguishment
    9       30       l       39  
Pension expense
    —         733       l       733  
Bad debt expense
    —         292       l       292  
Deferred income taxes, net
    144       (463     l, m, o, p       (319
Loss on disposal of property and equipment
    —         2       l       2  
Unrealized foreign exchange (gain)/loss
    —         1,019       l       1,019  
Loss on investments
    —         72       l       72  
Changes in assets and liabilities:
                               
Accounts receivable
    10,284       (7,219     a, l       3,065  
Manufacturing inventories
    (1,752     553       a, l       (1,199
Service parts inventories
    (2,737     353       l       (2,384
Accounts payable
    6,537       838       g, l       7,375  
Accrued warranty
    (313     313       l       —    
Accrued restructuring charges
    817       (1,114     e, f, g       (297
Accrued compensation
    (1,236     (1,031     i, l       (2,267
Deferred revenue
    (9,329     3,382       a, b, l       (5,947
Other assets and liabilities
    815       (3,728 )     a, d, g, h, l,
m, n, p, q
      (2,913
   
 
 
   
 
 
           
 
 
 
Net cash used in operating activities
    (304     (1,002             (1,306
   
 
 
   
 
 
           
 
 
 
Cash flows from investing activities:
                               
Purchases of property and equipment
    (1,156     5       l       (1,151
Proceeds from sale of assets
    —         275       l       275  
Cash distributions from investments
    278       —                 278  
   
 
 
   
 
 
           
 
 
 
Net cash used in investing activities
    (878     280               (598
   
 
 
   
 
 
           
 
 
 
Cash flows from financing activities:
                               
Borrowings of long-term debt and subordinated convertible debt, net of debt issuance costs
    164,650       620       k       165,270  
Repayments on long-term debt
    (160,245     4,479       k       (155,766
Repayment of convertible subordinated debt
    (6,000     (30     l       (6,030
Payment of tax withholding due upon vesting of restricted stock
    (1,775     (2     l       (1,777
Proceeds from issuance of common stock, net
    1,010       2       l       1,012  
   
 
 
   
 
 
           
 
 
 
Net cash provided by (used in) financing activities
    (2,360     5,069               2,709  
   
 
 
   
 
 
           
 
 
 
Effect of exchange rate changes on cash, cash equivalents and restricted cash
    82       247       l       329  
   
 
 
   
 
 
           
 
 
 
Net decrease in cash, cash equivalents and restricted cash
    (3,454     4,588               1,134  
Cash, cash equivalents and restricted cash at the beginning of period
    36,658       (746             35,912  
   
 
 
   
 
 
           
 
 
 
Cash, cash equivalents and restricted cash at the end of period
  $ 33,204     $ 3,842             $ 37,046  
   
 
 
   
 
 
           
 
 
 
Supplemental disclosure of cash flow information:
                               
Purchases of property and equipment included in accounts payable
  $ 335     $ (48     l     $ 287  
Transfer of inventory to property and equipment
  $ —       $ 919       l     $ 919  
Cash Paid For:
                               
Interest
  $ —       $ 4,515       l     $ 4,515  
Taxes, net of refunds
  $ —       $ 914       l     $ 914